Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (131-140 of 221) with videos related to

Pageof 23
Sort By:
Clinical and Experimental Rheumatology|December 25, 2018
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in ItalyGiuseppe Lopalco, Vincenzo Venerito, Jurgen Sota, et al.
Clinical Rheumatology|April 20, 2018
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumabClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Frontiers in Immunology|April 22, 2022
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids TaperingVincenzo Venerito, Giacomo Emmi, Luca Cantarini, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 2025
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case seriesLucia Trotta, Ruggiero Mascolo, Vartan Mardygan, et al.
Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.
Rheumatology (Oxford, England)|December 13, 2023
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation studyAlberto Floris, Riccardo Laconi, Gerard Espinosa, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Inflammopharmacology|March 12, 2020
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndromeElena Silvestri, Alice Bitossi, Alessandra Bettiol, et al.
Rheumatology (Oxford, England)|May 30, 2024
Exploring relief for Behçet's disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilastGiuseppe Lopalco, Maria Morrone, Vincenzo Venerito, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Pageof 23

Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Clinical and Experimental Rheumatology|December 25, 2018
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in ItalyGiuseppe Lopalco, Vincenzo Venerito, Jurgen Sota, et al.
Clinical Rheumatology|April 20, 2018
Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumabClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Frontiers in Immunology|April 22, 2022
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids TaperingVincenzo Venerito, Giacomo Emmi, Luca Cantarini, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 3, 2025
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case seriesLucia Trotta, Ruggiero Mascolo, Vartan Mardygan, et al.
Arthritis Research & Therapy|November 18, 2022
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up studyAlberto Floris, Matteo Piga, Riccardo Laconi, et al.
Rheumatology (Oxford, England)|December 13, 2023
Organ damage is a major determinant of work productivity impairment in Behçet's syndrome: a post hoc analysis of the BODI validation studyAlberto Floris, Riccardo Laconi, Gerard Espinosa, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Inflammopharmacology|March 12, 2020
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndromeElena Silvestri, Alice Bitossi, Alessandra Bettiol, et al.
Rheumatology (Oxford, England)|May 30, 2024
Exploring relief for Behçet's disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilastGiuseppe Lopalco, Maria Morrone, Vincenzo Venerito, et al.
Arthritis Research & Therapy|November 26, 2020
Discordance between patient and physician global assessment of disease activity in Behçet's syndrome: a multicenter study cohortAlberto Floris, Gerard Espinosa, Luisa Serpa Pinto, et al.
Pageof 23